Skip to content

Large Cohort of 1000 Patients With Severe Myopia

Large Cohort of 1000 Patients With Severe Myopia

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05849974
Acronym
MyoCo1000
Enrollment
1000
Registered
2023-05-09
Start date
2023-06-30
Completion date
2038-05-31
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Severe

Brief summary

The prevalence of myopia and severe myopia are increasing and will affect 50% and 10% of the population respectively. Severe myopia exposes an increased risk of glaucoma, cataract, retinal detachment and myopic maculopathy, a source of visual impairment. To date, no European cohort study has been conducted to estimate the rate of these complications and to study the predictive parameters.

Detailed description

This study allows to describe the evolution of different ophthalmological parameters of a population of strong myopes during their follow-up for 10 years using multimodal imaging techniques of the retina. Prospective, longitudinal, multicentric, non-randomized cohort study with constitution of a biological collection. This study will include major and minor patients with high myopia

Interventions

OTHERStructural and fonctional phynotyping

The additioan acts in this research are: Fonctionnal phenotyping:Retinal sensitivity and fixation stability assessment using microperimetry, assessment of long-term fixation stability Structural Phenotyping: Anterior segment examination with OCT anterior Blood sample collection

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
CollaboratorNETWORK
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective, longitudinal, multicentric, non-randomized cohort study with constitution of a biological collection. This study will include major and minor patients with high myopia

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 6 years * Severe myopia in at least one eye, defined as * a refractive error ≤ -6.00 diopters OR * an axial length ≥ 26.50 mm * Follow-up performed at at least one of the participating centers * Express consent to participate in the study * If age \< 18 years: express consent of the person(s) exercising parental authority * Affiliated or beneficiary of a health insurance

Exclusion criteria

* Visual acuity \< 5 letters on the ETDRS (equivalent to finger count or less) in both eyes * Disorders of the transparent media in both eyes with opacities that may affect image quality * Syndromic myopia of genetic origin (Stickler syndrome type 1 and 2, Marfan syndrome, Ehler-Danlos disease type 4, Knobloch syndrome) or inherited retinal dystrophy (X-linked retinitis pigmentosa, congenital stationary night blindness of Schubert-Bornshein type, Bornholm eye disease) * Patient who does not wish to continue to be followed in one of the participating centers * Patient benefiting from a legal protection measure * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
Anterior segment status10 yearsChamber measurement, corneal curvature (in mm)
Vitreous status10 yearsLiquefaction, stage of posterior vitreous detachment
Excavation of the optic nerve and area10 yearsIn mm² of peripapillary atrophy on color and autofluorescence images
Visual acuity10 yearsUsing the ETDRS and the near vision scale (decimal scales converted to logMAR)
Refraction measures10 yearsMeasure will be performed in diopter
Lens opacity10 yearsMeasure will be performed in pixel units
Intraocular pressure and pachymetry10 yearsThese measurements are respectively carried out in mmHg and in μm
Retinal sensitivity and fixation stability10 yearsRespectively Performed in decibels and by microperimetry
Central visual field deficits10 yearsby automatic perimetry in decibels
Axial length10 yearsWill be performed in mm
Quantitative data10 yearsOn optical coherence tomography (OCT) and OCT-Angiography
qualitative data on OCT :10 yearspresence of any macular complications: * condition of the posterior vitreous * presence of inner or outer retinal alteration (fluid, layer disorganization, band interruption...).
Area of Rétinal atrophy10 yearsIn autofluorescence (in mm²)
Characterization of the type of staphyloma10 yearsstaphyloma classification

Secondary

MeasureTime frameDescription
Non-macular ophthalmologic complications10 years* Glaucoma optic Neuropathy * Cataract * Retinal detachment
Macular ophthalmologic complications10 yearsDiffuse atrophy/patch atrophy/macular atrophy * Choroidal neovessel * Bruch's membrane rupture * Bulging macula * Papillary dysversion * Myopic staphyloma * Epiretinal membrane * Lamellar hole * Myopic foveoschisis * Macular hole

Contacts

Primary ContactNabil BROUK
nbrouk@15-20.fr+331 40 02 11 26
Backup ContactHayet SERHANE
hserhane@15-20.fr+331 40 02 11 44

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026